Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique

Journal of Biomedical Materials Research

Volumn 51, Issue 3, 2000, Pages 383-390

  King, Timothy W ^a   Patrick, Charles W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Drug delivery; Microspheres; Poly(DL lactide co glycolide); Polymer degradation; VEGF

Indexed keywords

BIODEGRADATION; CARBOXYLIC ACIDS; CONTROLLED DRUG DELIVERY; COPOLYMERS; ENCAPSULATION; MICROSCOPIC EXAMINATION; PARTICLE SIZE ANALYSIS; POLYESTERS; POLYETHYLENE GLYCOLS; PROTEINS; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION;

MICROSPHERES; POLYGLYCOLIC ACID; POLYLACTIC ACID;

BIOMATERIALS;

MACROGOL; MICROSPHERE; POLYGLACTIN; VASCULOTROPIN;

ANALYTIC METHOD; ARTICLE; BIODEGRADATION; BIOENGINEERING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HUMAN; HUMAN CELL; PARTICLE SIZE; PROTEIN SECRETION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; CATTLE; CELL DIVISION; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EMULSIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOKINES; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; RECOMBINANT PROTEINS; SOLVENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034609628     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D     Document Type: Article

References (45)

1. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-858.
2. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989;86:7311-7315.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
4. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995; 147:1649-1660.
5. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995;92:II365-II371.
6. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 1995;21:314-324; discussion 324-325.
7. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 1995;91:2802-2809.
8. Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM, Symes JF. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994;90:II228-II234.
9. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89: 2183-2189.
10. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93:662-670.
11. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol 1994;267:H1263-H1271.
12. Cao X, Schoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999;20:329-339.
13. Cleek RL, Rege AA, Denner LA, Eskin SG, Mikos AG. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J Biomed Mater Res 1997;35:525-530.
14. Cleland JL, Duenas ET. Controlled delivery of nerve growth factor for local treatment of neuronal disease. Proc Int Symp Control Del Bioact Mater 1997;24.
15. Cleland JL, Duenas ET, Kahn J, Park A, Daugherty A, Cuthbertson A. Local controlled delivery of vascular endothelial growth factor provides neovascularization. Proc Int Symp Control Del Bioact Mater 1997;24.
16. Cleland JL, Mac A, Boyd B, Yang J, Duenas ET, Yeung D, Brooks D, Hsu C, Chu H, Mukku V, Jones AJ. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 1997;14:420-425.
17. Cleland JL, Jones AJ. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm Res 1996;13: 1464-1475.
18. Lam XM, Duenas ET, Cleland JL. Stabilization of nerve growth factor during microencapsulation and release from microspheres. Proc Intl Symp Control Del Bioact Mater 1998;25.
19. Krewson CE, Dause R, Mak M, Saltzman WM. Stabilization of nerve growth factor in controlled release polymers and in tissue. J Biomater Sci Polym Ed 1996;8:103-117.
20. Mendez A, Camarata PJ, Suryanarayanan R, Ebner TJ. Sustained intracerebral delivery of nerve growth factor with biodegradable polymer microspheres. Methods Neurosci 1997;21: 150-167.
21. Morlock M, Kroll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin using biodegradable poly(D, L-lactide-co-glycolide): Protein stability and the effects of stabilizing exipients. Eur J Pharm Biopharm 1997;43:29-36.
22. Eppstein DA, Kurahara CG, Bruno NA, Van der Pas MA, Marsh YV, Schryver BB. Pathways to increasing efficacy of interferons: Drug synergy and sustained release. In: Stewart WE, Schellekens H, editors. Biology of the interferon system. New York: Elsevier, 1986. p 401-409.
23. Eppstein DA, Schryver BB. Controlled release of macromolecular polypeptides. US Patent 4 962 091; 1990.
24. Tracy MA, Bernstein H, Kahn MA. Controlled release of metalstabilized interferon. PTO Pub. No. WO96/03116; 1996.
25. Johnson OL, Jaworowicz W, Cleland JL, Bailey L, Charnis M, Duenas E, Wu C, Shepard D, Magil S, Last T, Jones AJ, Putney SD. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res 1997;14: 730-735.
26. Eiselt P, Kim BS, Chacko B, Isenberg B, Peters MC, Greene KG, Roland WD, Loebsack AB, Burg KJ, Culberson C, Halberstadt CR, Holder WD Jr., Mooney DJ. Development of technologies aiding large-tissue engineering. Biotechnol Prog 1998;14:134-140.
27. Mooney D, Kaufmann P, Sano K, Schwendeman S, Majahod K, Schloo B, Vacanti J, Langer R. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnol Bioeng 1996;50:422-429.
28. Edelman ER, Mathiowitz E, Langer R, Klagsbrun M. Controlled and modulated release of basic fibroblast growth-factor. Biomaterials 1991;12:619-626.
29. Gombotz WR, Pankey SC, Bouchard LS, Ranchalis J, Puolakkainen P. Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. J Biomater Sci Polym Ed 1993;5:49-63.
30. Hora MS, Rana RK, Nunberg JH, Tice TR, Gilley RM, Hudson ME. Controlled release of interleukin-2 from biodegradable microspheres. Biotechnology 1990;8:755-758.
31. Putney SD, Burke PA. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol 1998;16:153-157.
32. Tabata Y, Takebayashi Y, Ueda T, Ikada Y. A formulation method using D, L-lactic acid oligomer for protein release with reduced initial burst. J Control Release 1993;23:55-64.
33. Freshney RI. Culture of animal cells: A manual of basic technique. New York: Wiley-Liss, 1994. 486 p.
34. Visweswaran P, Johnson AD, Tock CL, Engler DA, Schwarz JJ, Casscells SW, Scott-Burden T. Stimulation of growth and migration of vascular endothelial cells by vascular endothelial growth factor transduced smooth muscle cells in co-culture. ASAIO J 1997;43:M753-M758.
35. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 1990;87:1323-1327.
36. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
37. Schneider AK. Polylactide sutures. US Patent 3 636 956; 1972.
38. Gilding DK. Biodegradable polymers. Biocompat Clin Implant Mater 1981;2:209-232.
39. Wise DL, Fellman TD, Sanderson JE, Wentworth RL. Lactic/glycolic acid polymers. In: Gregoriadis G, editor. Drug carriers in biology and medicine. London: Academic Press, 1979. p 237-270.
40. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 1991;8:713-720.
41. Iwata M, Tanaka T, Nakamura Y, McGinity JW. Selection of the solvent system for the preparation of poly(D, L lactic-co-glycolic acid) microspheres containing tumor-necrosis factor-alpha (TNF-α). Int J Pharm 1998;160:145-156.
42. Iwata M, Nakamura Y, McGinity JW. Particle size and loading efficiency of poly(D, L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods. J Microencapsulation 1999;16:49-58.
43. Tracy MA, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, Zhang Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 1999;20:1057-1062.
44. Garcia JT, Fariņa JB, Munguía O, Llabrés M. Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates. J Microencapsulation 1999;16:83-94.
45. Gabor F, Ertl B, Wirth M, Mallinger R. Ketoprofen-poly(D, L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsulation 1999;16:1-12.